RBM5 and breast carcinoma: Previous studies have shown that RBM5 mRNA and protein expression was frequently reduced in different cancers, including ras-transformed Rat-1 embryonic fibroblastic cells [7], breast cancer [8], human vestibular schwannoma [9], and primary lung cancer specimens [10,11].